Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    DaVita Inc.

    NYSE: DVA · Real-Time Price · USD
    136.58
    -3.31 (-2.37%)
    At close: May 28, 2025, 3:59 PM
    137.00
    0.31%
    After-hours: May 28, 2025, 04:44 PM EDT
    -2.37%
    Bid 136.27
    Market Cap 10.31B
    Revenue (ttm) 12.97B
    Net Income (ttm) 859.61M
    EPS (ttm) 10.2
    PE Ratio (ttm) 13.39
    Forward PE 10.75
    Analyst Hold
    Ask 138.75
    Volume 445,343
    Avg. Volume (20D) 881,648
    Open 138.63
    Previous Close 139.89
    Day's Range 136.50 - 139.29
    52-Week Range 131.76 - 179.60
    Beta 1.14

    About DVA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol DVA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for DVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    -11.09%
    DaVita shares are trading lower after the company ... Unlock content with Pro Subscription
    3 months ago
    +2.94%
    DaVita shares are trading lower. The company reported Q4 financial results.
    news image

    1 day ago · seekingalpha.com

    DaVita: International Expansion And Buybacks Will Boost Returns

    International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count...

    news image

    1 week ago · zacks.com

    Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    news image

    1 week ago · zacks.com

    Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    news image

    2 weeks ago · zacks.com

    DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

    Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.

    news image

    2 weeks ago · seekingalpha.com

    DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

    DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants...

    news image

    2 weeks ago · zacks.com

    DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

    DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.

    news image

    2 weeks ago · reuters.com

    DaVita beats quarterly profit estimates amid stable demand for dialysis services

    DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.

    news image

    2 weeks ago · investopedia.com

    DaVita First-Quarter 2025 Financial Results: Just the Numbers

    Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.

    news image

    2 weeks ago · zacks.com

    Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

    Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.

    news image

    3 weeks ago · zacks.com

    DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know

    DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session.

    Add to Watchlist